Searched for
BRAND LICENSING DEAL
Will Amber Enterprises shares rally in the near term after Oppo deal? Here’s what Nuvama, other brokerages sayAmber Enterprises’ partnership with Oppo has drawn mixed brokerage views, with Nuvama and PL Capital bullish on growth and diversification ...- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Amber Enterprises shares jump 3% after manufacturing partnership with Oppo IndiaAmber Enterprises India's shares surged after announcing a strategic manufacturing collaboration with Oppo Mobiles India. The partnership w...
- Why Amazon has struggled to crack IndiaAmazon's India strategy is changing: under new leadership, the company is focusing on profitability over rapid growth. This shift comes as ...
- Textile sector: Time for a relook as tariff tantrum may soon be history? 5 textile stocks with upside potential of up to 27%The Indian textile and apparel sector has had a stressful year. The US tariffs disrupted orders to the sector’s largest market, squeezed ma...
- Tata taps China's Chery for premium EV push, sources sayTata Motors is set to license an automaking platform from China's Chery. This collaboration aims to accelerate the launch of Tata's premium...
- How Trump has used the presidency to benefit himself and his alliesPresident Trump's administration is reviewing a large fund proposed for supporters. This comes amid scrutiny over various financial dealing...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- Lionsgate Play doubles down on India with AI, originals, Rs 1,000 crore IP goalLionsgate Play is set to invest heavily in creating intellectual property worth Rs 1,000 crore. The company is shifting towards becoming a ...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- As war settles, time to be bullish? Maybe: 5 stocks from different sectors with upside potential up to 24%After a weak 2025 and a not-so-great January-February 2026, the Indian mid- and small-cap segments followed the market as it headed south i...
- Zee Entertainment sues Nykaa for using its songs in Instagram reels without licenceZee Entertainment has sued Nykaa's parent company, FSN E-Commerce Ventures, for using its songs in Instagram promotions without permission....
- Zee sues Nykaa over alleged copyright misuse of songs on Instagram reelsZee Entertainment has filed a lawsuit against Nykaa. The company alleges Nykaa used its copyrighted songs in Instagram reels to promote pro...
- Tips Music promoters eye stake sale; talks with Universal stalledTips Music promoters are seeking to sell a minority stake to fund film content investments and strengthen music rights control. Previous ta...
- Times Music acquires Catrack Entertainment, doubles down on Punjabi catalogue strategyTimes Music has acquired Catrack Entertainment, a significant move to boost its regional music collection. This deal brings a valuable Punj...
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...
Load More
